SERPINA3 and metabolic dysfunction-associated steatohepatitis: In line with previous findings, our study observed lower levels of SERPINA3 or Serpina3k in both patients with MASH and mouse models, revealing an inverse relationship between KCTD17 and Serpina3k expression, which contributed to heightened liver fibrosis.